newsfilter
← Latest News
GlobeNewswire·

InMed Announces Update on Phase 2 Clinical Trial Investigating INM-755 Cannabinol Cream for Epidermolysis Bullosa

Phase 2 clinical trial recently expanded to include adolescents following independent review of early safety data First adolescent patient with EB enrolled into clinical trial and completed treatment International patent granted for the use of cannab